Unicommerce eSolutions Ltd

AI
Unicommerce Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Unicommerce eSolutions Ltd

₹ 76.7 -3.86%
23 Oct 2:54 p.m.
unicommerce.com BSE: 544227 NSE: UNIECOM
About

Incorporated in 2012, Unicommerce eSolutions Ltd manages e-commerce operations for brands, sellers, and logistics providers through its SaaS platform[1]

Key Points

Business Overview:[1][2][3]
UESL is India’s largest eCommerce enablement SaaS platform, orchestrating India’s eCommerce operations at scale and processing 25-30% of all dropship volumes in India in FY25. It streamlines eCommerce by automating brand and retailer operations across the value chain. Unicommerce enables multi-warehouse management, automated inventory decisions, AI-first capabilities, and omnichannel retail integration. The platform supports 7,596 clients across India, the Middle East, and Southeast Asia

Website BSE NSE
  • Market Cap ₹ 861 Cr.
  • Current Price ₹ 76.7
  • High / Low ₹ 139 / 75.1
  • Stock P/E 29.3
  • Book Value ₹ 19.9
  • Dividend Yield 0.00 %
  • ROCE 23.7 %
  • ROE 18.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 45.0% CAGR over last 5 years
  • Debtor days have improved from 35.9 to 21.1 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Software Software Products

Part of BSE Information Technology

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
25.16 25.93 25.96 26.53 27.47 29.31 29.47 27.46 27.73 29.65 31.84 30.66 31.28
22.54 22.33 21.41 22.89 23.27 23.60 21.01 19.28 19.34 20.95 21.31 20.41 22.54
Operating Profit 2.62 3.60 4.55 3.64 4.20 5.71 8.46 8.18 8.39 8.70 10.53 10.25 8.74
OPM % 10.41% 13.88% 17.53% 13.72% 15.29% 19.48% 28.71% 29.79% 30.26% 29.34% 33.07% 33.43% 27.94%
1.11 1.85 1.70 1.19 1.55 1.29 1.43 1.99 0.67 0.66 1.02 0.98 1.32
Interest 0.00 0.07 0.15 0.17 0.16 0.14 0.13 0.14 0.15 0.14 0.14 0.13 0.12
Depreciation 0.14 0.50 0.89 0.86 0.85 0.85 0.84 0.57 0.44 0.51 0.51 0.51 0.58
Profit before tax 3.59 4.88 5.21 3.80 4.74 6.01 8.92 9.46 8.47 8.71 10.90 10.59 9.36
Tax % 25.35% 24.39% 25.72% 24.21% 25.74% 25.62% 25.56% 25.37% 24.79% 25.95% 25.78% 26.16% 25.53%
2.68 3.69 3.88 2.88 3.51 4.47 6.64 7.06 6.36 6.45 8.10 7.83 6.97
EPS in Rs 0.52 0.72 0.66 0.49 0.60 0.44 0.65 0.68 0.62 0.58 0.72 0.70 0.62
Raw PDF
Upcoming result date: today

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
26 32 40 59 90 104 114 120 123
23 36 36 54 84 89 87 82 85
Operating Profit 3 -4 4 5 7 14 27 38 38
OPM % 10% -14% 9% 9% 7% 14% 23% 32% 31%
1 2 2 2 3 6 6 3 4
Interest 0 0 0 0 0 0 1 1 1
Depreciation 0 0 0 0 1 2 3 2 2
Profit before tax 4 -3 5 7 9 17 29 39 40
Tax % 34% 6% 17% 13% 27% 25% 26% 26%
3 -4 4 6 6 13 22 29 29
EPS in Rs 0.50 -0.70 0.88 1.17 1.27 2.23 2.10 2.56 2.62
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 10%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: 45%
3 Years: 64%
TTM: 20%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -40%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 20%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.02 0.02 0.02 0.02 0.02 6 10 11
Reserves 25 27 33 41 52 63 82 213
0 0 0 0 0 8 7 6
6 7 12 18 30 33 30 33
Total Liabilities 32 34 46 59 82 109 130 263
0 1 1 1 1 8 7 9
CWIP 0 0 0 0 0 0 2 0
Investments 0 4 0 0 6 6 72 195
31 29 45 58 75 95 48 60
Total Assets 32 34 46 59 82 109 130 263

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2 -4 10 8 15 6 29 46
1 -1 -3 -14 10 -30 -25 -44
0 0 0 0 0 -2 -3 -2
Net Cash Flow 3 -4 7 -6 25 -25 1 -0
Free Cash Flow 2 -4 10 7 14 6 22 45
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 180% 39% 187% 251% 279% 91% 109% 141%

Ratios

Standalone / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 32 43 84 55 48 47 40 21
Inventory Days
Days Payable
Cash Conversion Cycle 32 43 84 55 48 47 40 21
Working Capital Days -15 12 7 -23 68 191 48 -33
ROCE % -12% 18% 19% 19% 28% 32% 24%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Annual Recurring Revenue (ARR)
₹ Mn

Log in to view insights

Please log in to see hidden values.

Login
Revenue per Employee (Uniware)
₹ Mn
Share of Revenue from Top 10 Clients (Uniware)
%
Total Enterprise Clients (Uniware)
count
Number of items processed (Uniware)
Million
Shipway Annualised Revenue Run-rate
₹ Cr
Total Clients (Uniware + Shipway + Convertway)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
39.42% 39.42% 39.19% 39.19% 36.34% 36.01% 36.01% 36.01% 36.01%
2.30% 0.32% 0.42% 0.15% 0.25% 0.02% 0.15% 0.02% 0.03%
10.28% 8.07% 7.51% 6.12% 5.68% 5.47% 3.83% 2.38% 3.20%
47.99% 52.20% 52.88% 54.53% 57.72% 58.50% 60.01% 61.60% 60.76%
No. of Shareholders 1,00,8171,11,4601,11,1151,08,5621,04,7061,00,86098,35597,66395,310

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls